Abstract
Introduction School-aged autistic children commonly experience social communication and interaction challenges in their daily lives. While internationally evidence suggests that social skills group training (SSGT) programmes can support autistic children, improving their psycho-social functioning, to date there is no standardised evidence-based SSGT tailored towards the needs of children living in Mainland China. Therefore, this study will evaluate the feasibility, acceptability, preliminary efficacy, and cost-effectiveness of a culturally-adapted 16-session version of the KONTAKTTM programme in Chinese autistic children.
Methods and analysis This study will employed a randomised, single-blinded, wait-list controlled feasibility design with 36 Chinese autistic children aged 8 to 12 years with Intelligence Quotient over 70 referred to the Child Development Behaviour Centre, in Guangzhou, China. Participants will be randomly assigned to either the immediate training group (ITG) or the delayed training group (DTG) based on birth-assigned sex. Feasibility will be assessed using quantitative and qualitative data obtained from the KONTAKTTM participants, their parents, and facilitators of the programme. Preliminary efficacy and cost-effectiveness are assessed via quantitative data obtained at five-time points. The primary outcome is participants improvement in social skills as measured by the Contextual Assessment of Social Skills (CASS). Other outcomes include parents and teachers report of participants’ autistic trait and adaptive functioning, participants self-report and projective tests for self-assertiveness and psycho-social functioning, and parent report on parental reflective functioning and perceived school support. Common process factors and their effects on outcomes will also be explored. Cost-effectiveness will consider both societal and healthcare perspectives.
Ethics and dissemination The current study protocol has been reviewed and ethics approval has been obtained from the Ethical Board Committee at the Third Affiliated Hospital of Sun Yat-sen University (II2023-119-01). The trial has pre-registered in Chinese Clinical Trials (ChiCTR2300072136) on 05 June 2023. The results of this trial will be actively disseminated through peer-reviewed publications and conference presentations.
Strengths and limitations of this study
Comprehensive assessment of diverse outcomes via multiple informants.
Systematic cultural adaptation using the Integrative Cultural Adaptation Framework (ICAF) ensuring the appropriateness of the Chinese version of KONTAKTTM.
Collect data on readiness for change, providing insights into “help-seeker” effects.
Limited generalisability due to a single study site, location-specific inclusion, and absence of active comparator.
Uncertain psychometric properties of certain measures due to a lack of Chinese population data.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR2300072136
Clinical Protocols
https://www.chictr.org.cn/showproj.html?proj=195469
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethical Board Committee of the Third Affiliated Hospital of Sun Yat-sen University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(1)Enhanced Abstract: We have added more details about the study methodology in the Abstract section to provide a clearer overview. (2)Expanded Introduction: We have included additional information about the current needs and challenges faced by school-aged autistic children in China, strengthening the context of the study. (3)Streamlined Methods: We have rewritten the "Study Setting" section for improved readability and clarity. Additionally, we have provided more details about the cultural adaptations made for the trial. (4)Feasibility Framework Alignment: We have added a supplementary table (Online Supplementary File 2) that maps the focus areas of our feasibility study protocol to the framework outlined by Bowen et al., further demonstrating the study's rigorous design.
Data Availability
The ethical consent and funding documents have been reviewed by the review board of the Chinese Clinical Trial Registry and are available for review by the Editorial Office. Anonymised data related to this study will be available from the corresponding author upon reasonable request after study completion and publication of the study. The final dataset generated during this study will upload to the Research Data Deposit of Sun Yat-sen University. Trial results will be reported and published in scientific journals.
